Faculty profile

Marc Bilodeau

Back to faculty

ProfessorDépartement de médecineUniversité de Montréal

Marc Bilodeau

Professor

Département de médecine

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
4 publications in the last five years, latest in 2025.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2008.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

158

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

ResearchGate iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université de Montréal profile.

Latest papers

Integration of Non-invasive Screening for Cystic Fibrosis Related Liver Disease in the Regular Follow-Up for Cystic Fibrosis.
Digestive diseases and sciences · 2025
Fulminant liver failure due to Epstein-Barr virus in immunodeficiency disorders.
Canadian liver journal · 2025 · senior author
IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.
Diabetes · 2023

All 14 publications

Latest funding

Canadian Network on Hepatitis C (CanHepC): From Discovery to Implementation
CIHR · 2021 · Co-investigator
1st Workshop of the Canadian NonAlcoholic SteatoHepatitis (CanNASH) Network
CIHR · 2019 · Co-investigator
$12,500
The National CIHR Hepatitis C Network (NCHCN)
CIHR · 2015 · Co-investigator

All 8 grants and awards

14 publications.

Integration of Non-invasive Screening for Cystic Fibrosis Related Liver Disease in the Regular Follow-Up for Cystic Fibrosis.

Coman D, Bilodeau M, Vincent C, Brochiero E, Lavoie A, Hercun J

Digestive diseases and sciences20252 citations

DOI: 10.1007/s10620-024-08784-0 PMID: 39671064

Fulminant liver failure due to Epstein-Barr virus in immunodeficiency disorders.

Coman D, Hercun J, Corsilli D, Chapdelaine H, Cros G, Bilodeau M

Canadian liver journal2025Senior author

DOI: 10.3138/canlivj-2025-0019 PMID: 41725795

IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.

Gunes A, Schmitt C, Bilodeau L, Huet C, Belblidia A, Baldwin C, Giard JM, Biertho L, Lafortune A, Couture CY, Cheung A, Nguyen BN, Galun E, Bémeur C, Bilodeau M, Laplante M, Tang A, Faraj M, Estall JL

Diabetes202334 citationsOpen Access

DOI: 10.2337/db23-0171 PMID: 37757741

Signaling by the tyrosine kinase Yes promotes liver cancer development.

Guégan JP, Lapouge M, Voisin L, Saba-El-Leil MK, Tanguay PL, Lévesque K, Brégeon J, Mes-Masson AM, Lamarre D, Haibe-Kains B, Trinh VQ, Soucy G, Bilodeau M, Meloche S

Science signaling2022

DOI: 10.1126/scisignal.abj4743 PMID: 35041461

Targeted caspofungin prophylaxis for invasive aspergillosis in high-risk liver transplant recipients, a single-center experience.

Chakravarti A, Butler-Laporte G, Carrier FM, Bilodeau M, Huard G, Corsilli D, Savard P, Luong ML

Transplant infectious disease : an official journal of the Transplantation Society20215 citations

DOI: 10.1111/tid.13568 PMID: 33450126

Oxaloacetate Protects Rat Liver From Experimental Warm Ischemia/Reperfusion Injury by Improving Cellular Energy Metabolism.

Merlen G, Raymond VA, Cassim S, Lapierre P, Bilodeau M

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2019Senior author

DOI: 10.1002/lt.25415 PMID: 30663275

Reply to: “Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?”

Mamatha Bhat, Peter Ghali, Marc Bilodeau

Journal of Hepatology2017Senior author

DOI: 10.1016/j.jhep.2017.03.019 PMID: 28347800

Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.

Faisal N, Bilodeau M, Aljudaibi B, Hirsch G, Yoshida EM, Hussaini T, Ghali MP, Congly SE, Ma MM, Leonard J, Cooper C, Peltekian K, Renner EL, Lilly LB

Transplantation201636 citations

DOI: 10.1097/tp.0000000000001126 PMID: 26950722

Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics

Mamatha Bhat, Peter Ghali, Benoît Dupont, Roy Avraham Hilzenrat, Mahmood Tazari, André Roy, Prosanto K. Chaudhury, Fernando Villar Álvarez, Michel Carrier, Marc Bilodeau

Journal of Hepatology201626 citationsSenior author

DOI: 10.1016/j.jhep.2016.10.008 PMID: 27751840

Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience

Nabiha Faisal, Eric M. Yoshida, Marc Bilodeau, Philip Y.N. Wong, Mang M. Ma, Kelly W. Burak, Bandar Al‐Judaibi, Eberhard L. Renner, Leslie Lilly

Annals of Hepatology201429 citationsOpen Access

DOI: 10.1016/s1665-2681(19)31252-9 PMID: 25152985

Canadian Network on Hepatitis C (CanHepC): From Discovery to Implementation

Co-investigatorCIHR2021Hepatitis C Research

Principal investigators: Shoukry, Naglaa H; Dickie, Melisa C; Bruneau, Julie; Feld, Jordan J; Grimshaw, Jeremy M; Janjua, Naveed Z; King, Alexandra; Richardson, Christopher D

Keywords: Cascade Of Care; Diagnosis; Direct Acting Antivirals; Hepatitis C; Implementation Science; Long-Term Outcomes; Prevention; Priority Populations

1st Workshop of the Canadian NonAlcoholic SteatoHepatitis (CanNASH) Network

Co-investigatorCIHR2019Planning and Dissemination Grant - Institute Community Support

Principal investigators: Sebastiani, Giada

Keywords: Diabetes; Fatty Liver; Metabolic Syndrome; Nash

$12,500

The National CIHR Hepatitis C Network (NCHCN)

Co-investigatorCIHR2015Team Grant: National Hepatitis C Collaborative Network

Principal investigators: Shoukry, Naglaa H; Wong, Thomas; Bruneau, Julie; Feld, Jordan J; Krajden, Mel; Richardson, Christopher D

Keywords: Aboriginals; Hepatitis C; Liver Cancer; Liver Disease; People Who Inject Drugs; Public Health; Risk Factors; Therapy; Vaccines; Viral Transmission

Fourth Canadian Symposium on Hepatitis C Virus

Co-investigatorCIHR2014Planning and Dissemination Grant - Institute Community Support

Principal investigators: Wilson, Joyce A

Keywords: Barriers To Care; Disease Burden; Epidemiology; Hepatitis C; National Action Plan; Public Health; Social Sciences; Viral Hepatitis; Virology

$10,000

Third Canadian Symposium on Hepatitis C Virus

Co-investigatorCIHR2013Dissemination Events - Priority Announcement: Infection and Immunity

Principal investigators: Feld, Jordan J

Keywords: Access To Care; Epidemiology; Hepatitis C; Immunology; Public Health; Social Sciences; Viral Hepatitis; Virology

$25,000

Second Canadian Symposium on Hepatitis C Virus

Co-investigatorCIHR2012Dissemination Events - Priority Announcement: Hepatitis C

Principal investigators: Krajden, Mel

Keywords: Access To Care; Antivirals; Epidemiology; Hcv; Hepatitis C; Immunology; Interferon; Social Sciences; Viral Hepatitis; Virology

Canadian Symposium on Hepatitis C Virus

Co-investigatorCIHR2011Dissemination Events - Priority Announcement: Hepatitis C

Principal investigators: Shoukry, Naglaa H

Keywords: Access To Care; Anti-Virals; Epidemiology; Hcv; Hepatitis C; Immunology; Interferon; Social Sciences; Viral Hepatitis; Virology

$19,920

National CIHR Research Training Program in Hepatitis C- Subvention nationale de formation des IRSC en hépatite C

Nominated PICIHR2008Training Grant

Principal investigators: Bilodeau, Marc

Keywords: Education; Hiv Co-Infection; Knowledge Translation; Research Methodology; Transdisciplinary; Viral Hepatitis

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Marc Bilodeau

Research

Latest papers

Latest funding

Integration of Non-invasive Screening for Cystic Fibrosis Related Liver Disease in the Regular Follow-Up for Cystic Fibrosis.

Fulminant liver failure due to Epstein-Barr virus in immunodeficiency disorders.

IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.

Signaling by the tyrosine kinase Yes promotes liver cancer development.

Targeted caspofungin prophylaxis for invasive aspergillosis in high-risk liver transplant recipients, a single-center experience.

Oxaloacetate Protects Rat Liver From Experimental Warm Ischemia/Reperfusion Injury by Improving Cellular Energy Metabolism.

Reply to: “Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?”

Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.

Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics

Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience

Frequent collaborators

Daniel Corsilli

An Tang

Mamatha Bhat

Nabiha Faisal

Eric Yoshida

Daniel Lamarre

Hugo Chapdelaine

Guilhem Cros

Catherine Vincent

Angela Cheung

Benjamin Haibe-Kains

Anne-Marie Mes-Masson

Emmanuelle Brochiero

Sylvain Meloche

Chantal Bémeur

Laurent Biertho

François Carrier

Guillaume Butler-Laporte

Claude Kauffmann

Mang Ma

Mathieu Laplante

Me-Linh Luong

May Faraj

Gilles Soulez